Romosozumab Use to Build Skeletal Integrity
Clinical trial NCT05058976 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05058976
- Sponsor
- Susan L. Greenspan
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2027-03-31
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.